Literature DB >> 27666502

WANTED - Dead or alive: Myotubularins, a large disease-associated protein family.

Matthieu A Raess1, Sylvie Friant2, Belinda S Cowling3, Jocelyn Laporte4.   

Abstract

Myotubularins define a large family of proteins conserved through evolution. Several members are mutated in different neuromuscular diseases including centronuclear myopathies and Charcot-Marie-Tooth (CMT) neuropathies, or are linked to a predisposition to obesity and cancer. While some members have phosphatase activity against the 3-phosphate of phosphoinositides, regulating the phosphorylation status of PtdIns3P and PtdIns(3,5)P2 implicated in membrane trafficking and autophagy, and producing PtdIns5P, others lack key residues in the catalytic site and are classified as dead-phosphatases. However, these dead phosphatases regulate phosphoinositide-dependent cellular pathways by binding to catalytically active myotubularins. Here we review previous studies on the molecular regulation and physiological roles of myotubularins. We also used the recent myotubularins three-dimensional structures to underline key residues that are mutated in neuromuscular diseases and required for enzymatic activity. In addition, through database mining and analysis, expression profile and specific isoforms of the different myotubularins are described in depth, as well as a revisited protein interaction network. Comparison of the interactome and expression data for each myotubularin highlights specific protein complexes and tissues where myotubularins should have a key regulatory role.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Congenital myopathy; GTEx database; Myotubular myopathy; Myotubularin; Neuropathy; Sbf1

Mesh:

Substances:

Year:  2016        PMID: 27666502     DOI: 10.1016/j.jbior.2016.09.001

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  21 in total

Review 1.  Promoter DNA hypermethylation - Implications for Alzheimer's disease.

Authors:  Yiyuan Liu; Minghui Wang; Edoardo M Marcora; Bin Zhang; Alison M Goate
Journal:  Neurosci Lett       Date:  2019-07-24       Impact factor: 3.046

2.  Antagonistic control of active surface integrins by myotubularin and phosphatidylinositol 3-kinase C2β in a myotubular myopathy model.

Authors:  Paula Samsó; Philipp A Koch; York Posor; Wen-Ting Lo; Hassane Belabed; Marc Nazare; Jocelyn Laporte; Volker Haucke
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

3.  Adult MTM1-related myopathy carriers: Classification based on deep phenotyping.

Authors:  Benjamin T Cocanougher; Lauren Flynn; Pomi Yun; Minal Jain; Melissa Waite; Ruhi Vasavada; Jason D Wittenbach; Sabine de Chastonay; Sameer Chhibber; A Micheil Innes; Linda MacLaren; Tahseen Mozaffar; Andrew E Arai; Sandra Donkervoort; Carsten G Bönnemann; A Reghan Foley
Journal:  Neurology       Date:  2019-09-20       Impact factor: 9.910

Review 4.  Phosphoinositides in autophagy: current roles and future insights.

Authors:  Lavinia Palamiuc; Archna Ravi; Brooke M Emerling
Journal:  FEBS J       Date:  2019-11-21       Impact factor: 5.622

5.  A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs).

Authors:  Davide Pareyson; Tanya Stojkovic; Mary M Reilly; Sarah Leonard-Louis; Matilde Laurà; Julian Blake; Yesim Parman; Esra Battaloglu; Meriem Tazir; Mounia Bellatache; Nathalie Bonello-Palot; Nicolas Lévy; Sabrina Sacconi; Raquel Guimarães-Costa; Sharham Attarian; Philippe Latour; Guilhem Solé; André Megarbane; Rita Horvath; Giulia Ricci; Byung-Ok Choi; Angelo Schenone; Chiara Gemelli; Alessandro Geroldi; Mario Sabatelli; Marco Luigetti; Lucio Santoro; Fiore Manganelli; Aldo Quattrone; Paola Valentino; Tatsufumi Murakami; Steven S Scherer; Lois Dankwa; Michael E Shy; Chelsea J Bacon; David N Herrmann; Alberto Zambon; Irene Tramacere; Chiara Pisciotta; Stefania Magri; Stefano C Previtali; Alessandra Bolino
Journal:  Ann Neurol       Date:  2019-05-27       Impact factor: 11.274

Review 6.  Phosphoinositides, Major Actors in Membrane Trafficking and Lipid Signaling Pathways.

Authors:  Johan-Owen De Craene; Dimitri L Bertazzi; Séverine Bär; Sylvie Friant
Journal:  Int J Mol Sci       Date:  2017-03-15       Impact factor: 5.923

7.  A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus study.

Authors:  Alan H Beggs; Barry J Byrne; Sabine De Chastonay; Tmirah Haselkorn; Imelda Hughes; Emma S James; Nancy L Kuntz; Jennifer Simon; Lindsay C Swanson; Michele L Yang; Zi-Fan Yu; Sabrina W Yum; Suyash Prasad
Journal:  Muscle Nerve       Date:  2017-12-22       Impact factor: 3.217

8.  An In Vitro Model of Charcot-Marie-Tooth Disease Type 4B2 Provides Insight Into the Roles of MTMR13 and MTMR2 in Schwann Cell Myelination.

Authors:  Danielle C Robinson; Anna E Mammel; Anne M Logan; Aubree A Larson; Eric J Schmidt; Alec F Condon; Fred L Robinson
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

Review 9.  The Roles of Pseudophosphatases in Disease.

Authors:  Andrew M Mattei; Jonathan D Smailys; Emma Marie Wilber Hepworth; Shantá D Hinton
Journal:  Int J Mol Sci       Date:  2021-06-28       Impact factor: 5.923

Review 10.  Centronuclear myopathies under attack: A plethora of therapeutic targets.

Authors:  Hichem Tasfaout; Belinda S Cowling; Jocelyn Laporte
Journal:  J Neuromuscul Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.